Hyperfine, Inc. (HYPR)
Pre-market:
| Previous close | 0.8874 |
| Open | 0.9000 |
| Bid | 0.8877 x 100 |
| Ask | 0.9479 x 200 |
| Day's range | 0.8804 - 1.0299 |
| 52-week range | 0.7610 - 3.2800 |
| Volume | |
| Avg. volume | 97,637 |
| Market cap | 65.527M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference
GUILFORD, Conn., May 22, 2024--Hyperfine, Inc. to present at the Jefferies Global Healthcare Conference
- Business Wire
Hyperfine, Inc. Celebrates ASNR 2024
LAS VEGAS, May 22, 2024--The 2024 ASNR Annual Meeting had a strong focus on Alzheimer’s disease care and growing excitement about ultra-low-field MRI
- GlobeNewswire
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update. “We have kicked off 2024 strong. I am pleased with our commercial progress shown by sales across US and international accounts, as well as the important mil
